Form 4 Filing: Stock Option Granted to CEO and Chairman Ilya M. Rachman

This filing reports a Form 4 for Immix Biopharma, Inc. (IMMX), detailing a stock option grant to Ilya M. Rachman, CEO and Chairman. The option, exercisable for 500,000 shares of Common Stock, was granted on May 22, 2026, with an exercise price of $8.78 per share and an expiration date of May 22, 2036. The option vests in 48 equal monthly installments, contingent upon Mr. Rachman's continued service with the company. This transaction is classified as an acquisition of securities under a compensatory benefit plan. The filing indicates direct ownership, with post-transaction shares held by Mr. Rachman amounting to 500,000 shares.